Clinical trial
An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant…
NCT00052052 · InterMune, Industry · Completed
Key facts
| NCT number | NCT00052052 |
|---|---|
| Title | An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
| Official title | An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis. |
| Lead sponsor | InterMune, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Disease, Pulmonary Fibrosis |
| Intervention type | Drug |
| Interventions | interferon-gamma 1b |
| Enrollment | 210 |
| Start date | Sep 1, 2002 |
| Completion | Sep 1, 2004 |
| First posted | Jan 23, 2003 |
| Last update posted | Nov 6, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: